Advertisement
research summary
research summary
03/26/2024

Leigh Precopio

Leigh Precopio
Researchers examined if venetoclax—a therapy commonly used in the treatment of acute myelogenous leukemia and chronic lymphocytic leukemia—was associated with an increased risk of opportunistic infections,...
03/26/2024
research summary
research summary
11/30/2023

Leigh Precopio

Leigh Precopio
Individuals with acute myeloid leukemia often have low levels of vitamin C and vitamin D at the time of diagnosis. Researchers examined how supplementation of these vitamins during treatment impacted...
11/30/2023
Research Summary
Research Summary
11/17/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine whether DNA sequencing of the blood from adults with acute myeloid leukemia in remission before allogeneic hematopoietic cell transplant could detect residual variant...
11/17/2023
Research Summary
Research Summary
10/26/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine the impact of midostaurin in adult patients with FLT3-mutated acute myeloid leukemia.
10/26/2023
fda alert
fda alert
10/19/2023

Leigh Precopio

Leigh Precopio
The FDA approved the use of quizartinib for certain patient populations with acute myeloid leukemia in July 2023.
10/19/2023
Conference Coverage
Conference Coverage
09/29/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers retrospectively identified patients with CNS AML and evaluated several treatments and outcomes for this type of cancer at two large academic institutions.
09/29/2023
Research Summary
Research Summary
09/20/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers performed a retrospective observational study to determine whether DNA sequencing can detect residual disease in adults with acute myeloid leukemia (AML) in first remission.
09/20/2023
Conference Coverage
Conference Coverage
09/06/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine whether cancer-related cognitive impairment impacts older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy.
09/06/2023
Immunology
vaccine
Immunology
01/17/2022
The researchers aimed to clarify whether protective immunity in response to SARS-CoV-2 vaccines will develop in patients with acute myeloid leukemia or myelodysplastic syndrome by enrolling patients at...
01/17/2022
diagnosis
diagnosis
01/12/2022
The researchers evaluated the accuracy of WGS and WTS in determining diagnostic subgroups in 1100 patients with acute myeloid leukemia, B-cell precursor acute lymphoblastic leukemia, or T-cell acute...
01/12/2022